Nicaragua vs Solomon Islands: The number of people with susceptibility test result for rifampicin
Nicaragua
46.72
in 2021
Solomon Islands
45.52
in 2021
Nicaragua rank
117th
Solomon Islands rank
118th
The number of people with susceptibility test result for rifampicin over time
- Nicaragua
- Solomon Islands
How they compare
Nicaragua currently reports 46.72 against 45.52 in Solomon Islands, a difference of 1.2.
Across all 5 years both countries report, Nicaragua has been ahead every year.
Nicaragua ranks 117th and Solomon Islands ranks 118th of 146 countries.
Nicaragua has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nicaragua | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 44.17 | 0 | 44.17 | Nicaragua |
| 2020s | 71.24 | 55.88 | 15.35 | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Nicaragua or Solomon Islands?
- Nicaragua, at 46.72 against 45.52 in Solomon Islands as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Nicaragua and Solomon Islands?
- 1.2, with Nicaragua ahead.
- How many years of comparable data are there for Nicaragua and Solomon Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Nicaragua and Solomon Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Nicaragua ranks 117th and Solomon Islands ranks 118th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.